Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD

Aliya F. Gulamhusein, John E. Eaton, James H. Tabibian, Elizabeth J. Atkinson, Brian D. Juran, Konstantinos N. Lazaridis

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Duration of inflammatory bowel disease is associated with increased risk of cholangiocarcinoma in patients with primary sclerosing cholangitis and IBD'. Together they form a unique fingerprint.

Medicine & Life Sciences